Autologous or allogeneic bone marrow transplant causes dramatic increases in T cell p16 levels and senescence-related gene expression signatures associated with clinical frailty in patients with hematologic malignancies [15, 17]. The gene discussed is CDKN2A; the disease is hematologic disorder.